Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

/CNW/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies...

ONCY : 0.9700 (+7.09%)
RPTX : 1.3500 (unch)
IMRX : 2.25 (+2.27%)
ONC.TO : 1.41 (+9.30%)
RNXT : 1.2900 (+1.57%)
CRGX : 14.66 (-0.41%)
Stocks in play: Oncolytics Biotech Inc

Is providing a recap of the major accomplishments from 2024 and a preview of the milestones that are ...

BLX.TO : 29.21 (+0.62%)
ONC.TO : 1.41 (+9.30%)
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, is providing a recap...

ONCY : 0.9700 (+7.09%)
ONC.TO : 1.41 (+9.30%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.9700 (+7.09%)
CKPT : 3.64 (+2.82%)
PSNL : 6.09 (+2.35%)
ONC.TO : 1.41 (+9.30%)
TEM : 34.79 (-0.34%)
CRDF : 3.92 (-3.69%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.9700 (+7.09%)
CKPT : 3.64 (+2.82%)
PSNL : 6.09 (+2.35%)
ONC.TO : 1.41 (+9.30%)
TEM : 34.79 (-0.34%)
CRDF : 3.92 (-3.69%)
From Crisis to Opportunity: How Advances in Immunotherapy Are Shaping the Oncology Sector

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite significant advances in oncology research, challenges remain as the American Cancer Society...

ONCY : 0.9700 (+7.09%)
PYXS : 1.6000 (-4.19%)
RPTX : 1.3500 (unch)
IMRX : 2.25 (+2.27%)
CVM : 0.7000 (+0.29%)
ONC.TO : 1.41 (+9.30%)
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments

/CNW/ -- USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...

ONCY : 0.9700 (+7.09%)
CKPT : 3.64 (+2.82%)
LLY : 795.67 (-0.08%)
ONC.TO : 1.41 (+9.30%)
OSTX : 3.83 (+1.32%)
CRDF : 3.92 (-3.69%)
Stocks in play: Oncolytics Biotech Inc.

Announced the presentation of two data sets through two abstracts showcasing pelareorep's potential ...

ONC.TO : 1.41 (+9.30%)
Early-Onset Cancer Trends Spark Interest in Promising Oncology Pipelines

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society has unveiled its Advances in Oncology – 2024 Research Highlights report,...

ONCY : 0.9700 (+7.09%)
PSNL : 6.09 (+2.35%)
ALXO : 1.8300 (-2.14%)
ONC.TO : 1.41 (+9.30%)
NVCT : 4.65 (+1.53%)
TEM : 34.79 (-0.34%)
Stocks in play: Oncolytics Biotech Inc

Today announced the presentation of two data sets through two abstracts showcasing pelareorep's potential ...

ONC.TO : 1.41 (+9.30%)

Barchart Exclusives

Ford Stock 2025 Price Prediction: Will F Continue Paying Fat Dividends?
Ford stock is set to close in the red in 2024. However, its juicy dividend payouts could continue into the new year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar